Meet us at CPHI 2024
Month: August 2024
Meet us at CPHI 2024
Discover our Next Generation controlled, continuous RheaLyo™ freeze-drying technology.
Check out our booth #18C85 to watch a live demo.
From 8-10 October, our process specialists will be glad to present the latest developments:
RheaLyo™ Mono freeze-dryer: Our Single Vial Unit for R&D. Fast and optimal formulation and process development. Now with BSL2 integration!
RheaLyo™ Multi freeze-dryer: Our Multi Vial Unit for non-GMP stability study productions.
RheaLyo™ GMP-Flex production lines: For clinical and commercial productions.
Get exclusive insights on RheaVita’s way to Continuous Lyophilization and discover how this technology may drive your economics, quality and flexibility.
RheaVita: we take the pain out of biopharmaceutical freeze-drying.
For the most up to date news, please follow us on LinkedIn via the link below
Taking Lyophilization for a Spin
Month: August 2024
Continuous freeze-drying of mRNA LNPs enables storage at higher temperatures
The pharmaceutical industry is increasingly recognizing the need to speed up and improve the lyophilization process, specifically for mRNA LNP-based vaccines and in the event of any future pandemic preparedness requirements. Thus, Thomas De Beer, Laboratory of Pharmaceutical Process Analytical Technology, Ghent University, Belgium, helped pioneer a spin freeze drying stabilization technique that could bring about an end to frozen mRNA vaccine storage – with the additional benefit of moving away from batch towards Continuous Lyophilization with a New Technique: Spin Freeze Drying continuous processing and manufacturing.
For the most up to date news, please follow us on LinkedIn via the link below